Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Department of Emergency Medicine, Madigan Army Medical Center, Tacoma, Washington